BioSpace News Archive

PerkinElmer, Inc, today announced that the Company will present at the virtual Baird Global Healthcare Conference on Tuesday, September 14, 2021 at 10:50 a.m. ET.

Cerba Research announced today that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan covering the Asia Pacific region.

Palisade Bio, Inc. today provides a business update and releases its financial results for the second quarter ending June 30, 2021.

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, announced that the European Commission has granted orphan designation for AOC 1001.

OmniPathology, an independent, physician-owned and operated pathology lab, announced a new alliance with PRIVIT, creators of PRIVIT Pass, that will enable faster reporting of COVID-19 test results for students, faculty, employees, athletes, or any group that needs regular testing for the presence of the coronavirus.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced the appointment of Tomoko Maeda-Chubachi, MD, PhD, MBA as Chief Medical Officer.

Reistone Biopharma (“Reistone”), a leading biotech focused on development of treatments for immune & inflammation related diseases, today announced positive topline results from a Phase 2 study evaluating the safety and effectiveness of once-daily SHR0302 in adults with alopecia areata (AA).

Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB:NPTX), a socially responsible pain management life sciences company, today announces the formation of Dermique Incorporated (“Dermique”), a new wholly owned subsidiary to hold, manage, commercialize and market the intellectual property assets related to the company’s cosmeceutical ingredients (“OTC IP”).

Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced U.S. Food and Drug Administration (FDA) approval of its newest-generation, self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut™ FX TAVR system.

CB Therapeutics is a leading biosynthesis company focused on the research and development of environmentally-friendly products to improve mental health, increase healthspan, and promote longevity.